Chemical Structure (Omnipaque Cork 01)
Omnipaque Injection, Solution
Product Images NDC 0407-1401
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Omnipaque (NDC 0407-1401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ge Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Omnipaque Cork 02)
Not available*
Principal Display Panel (140 mgI/mL Bottle Label)
This is a description of a medical injectable product called OMNIPAQUE™, which is an iohexol injection used for diagnostic imaging procedures. The pH of the solution is adjusted between 6.8 and 7.7, and no preservatives are added. Each vial is meant for one-time use only, and any unused portion should be discarded. The product should be protected from light, stored at a temperature of 20°- 25°C, and not frozen. For more information on indications and dosage, refer to the package insert. The product is distributed by GE Healthcare Inc, and inquiries can be made by calling 1-800-654-0118.*
Principal Display Panel (180 mgI/mL Vial Label)
Principal Display Panel (240 mgI/mL Bottle Label)
Description not available.*
Principal Display Panel (300 mgI/mL Bottle Label)
Description not available. The text contains incomplete and unrelated words and phrases, possibly due to distortion during the process.*
Principal Display Panel (350 mgI/mL Bottle Label)
This is a description of two pharmaceutical products by GE Healthcare. The first product is a pH solution that needs to be stored between 15 and 30 degrees Celsius and is intended for oral use only. The second product is a single-dose bottle of OMNIPAQUE™ oral solution that contains iohexal, organic bound odinl, womethaming, and adetate colcum dsodm. It is distributed by GE Healthcare and is considered a sterile aqueous solution that does not require dilution. There are instructions indicating the unused portion should be discarded and that the product should be protected from light. Additionally, for indications and dosage information, refer to the package insert. Non-English characters are excluded from this text.*
Omnipaque Cork 08
This is a description of GE Healthcare's product 'OMNIPAQUE', which is an oral solution containing 12 mg iodine/m. The pH should be adjusted to between 6 and 7 with hydrochloric acid or sodium hydroxide, and the solution should not have any added preservatives. The recommended storage temperature is between 0 and 30°C (52-86°F). Each 1 ml of the solution contains 26 mg of iohexol (12 mg organically bound iodine), 1.21 mg of tromethamine, and 0.015 mg of edetate calcium sodium. The solution is distributed by GE Healthcare Inc. and is for oral use only. For more information on indications and dosage, see the package insert. The product is a sterile aqueous solution that comes in a single-dose bottle, and it should be discarded after use.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
